Charleston Laboratories, Daiichi Sankyo receives FDA acceptance for CL-108 NDA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2016
Singapore: New Jersey's Charleston Laboratories Inc and Japanese major Daiichi Sankyo Inc have announced that the US Foo...Read more
German firm proceeds on ebola vaccine trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...Read more
Australian researchers find key gene behind Type 2 Diabetes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 May, 2016
A finding, published in the Latin American Herald Tribune, says that a genetic study of people with Down's syndrome help...Read more
Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 21 Aug, 2015
Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...Read more
Novartis buys GSK's antibody drug, Ofatumumab
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015
Singapore: Novartis has proceeded to acquire all remaining rights of GSK's Ofatumumab, a fully human monoclonal antibo...Read more
Bionomics files patent application for cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2015
Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...Read more
Teijin, Pulmagen enter agreement for asthma drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012
Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...Read more
FDA approves Novartis' drug for rare blood disorder
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2015
Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...Read more
Agilent, Queensland univ join hands for cancer research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2013
Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...Read more
CrystalGenomics partners with Dong-A for Acelex commercialization
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2015
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...Read more
Japanese researchers discover potential drug target for muscle disease
Drug Discovery | News | By BioSpectrum Bureau | 1 Comment | 24 Aug, 2015
Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...Read more
AMRI acquires spanish API firm at $174 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2015
Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...Read more
Kowa, Chugai to market liver cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...Read more
SCIEX expands lipidomics portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2015
Singapore: SCIEX, a life science analytical technologies provider, and Metabolon, a global company focused on metabolomi...Read more
RaQualia, Interprotein to research on pain drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...Read more
Novartis gets EU nod for combination therapy for skin cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2015
Singapore: European Medicines Agency (EMA) has given a positive indication to Novartis' combination therapy of Tafinlar ...Read more
Chemistry Nobel winner, Dr Irwin Rose, dies at 88
Drug Discovery | Influencers | By BioSpectrum Bureau | 5 Comment | 04 Jun, 2015
Singapore: Dr Irwin Rose, an American biologist, who shared Nobel Prize in Chemistry in 2004 for the discovery of cell b...Read more
Novartis' Enbrel positive in psoriasis study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: Novartis' phase III psoriasis study of secukinumab (AIN457) has showed positive outcome in clearing skin to E...Read more